UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

Journal of clinical oncology, 2014-09, Vol.32 (25), p.2735-2743

2014

Volltextzugriff (PDF)

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

Journal of clinical oncology, 2018-05, Vol.36 (14), p.1412-1418

2018

Volltextzugriff (PDF)

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

The Lancet (British edition), 2016-07, Vol.388 (10043), p.488-497

2016

Volltextzugriff (PDF)

Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies

Drugs (New York, N.Y.), 2017-05, Vol.77 (8), p.843-857

2017

Volltextzugriff (PDF)

OER‐073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma

Cancer, 2022-10, Vol.128 (19), p.3516-3522

2022

Volltextzugriff (PDF)

Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma

Journal of clinical oncology, 2007-08, Vol.25 (24), p.3766-3773

2007

Volltextzugriff (PDF)

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3978-3984

2007

Volltextzugriff (PDF)

Promising New Molecular Targeted Therapies in Head and Neck Cancer

Drugs (New York, N.Y.), 2013-03, Vol.73 (4), p.315-325

2013

Volltextzugriff (PDF)

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

Cancer, 2012-03, Vol.118 (6), p.1486-1497

Agulnik, Mark

2012

Volltextzugriff (PDF)

Salivary Gland Malignancies: The Role for Chemotherapy and Molecular Targeted Agents

Seminars in oncology, 2008-06, Vol.35 (3), p.309-319

2008

Volltextzugriff (PDF)

Evolving strategies for management of desmoid tumor

Cancer, 2022-08, Vol.128 (16), p.3027-3040

2022

Volltextzugriff (PDF)

Impact and Perceptions of Mandatory Tumor Biopsies for Correlative Studies in Clinical Trials of Novel Anticancer Agents

Journal of clinical oncology, 2006-10, Vol.24 (30), p.4801-4807

2006

Volltextzugriff (PDF)

Predictive and Pharmacodynamic Biomarker Studies in Tumor and Skin Tissue Samples of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Erlotinib

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2184-2190

2007

Volltextzugriff (PDF)

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma

Journal of clinical oncology, 2019-06, Vol.37 (16), p.1424-1431

2019

Volltextzugriff (PDF)

Phase 1/2 study of devimistat in combination with hydroxychloroquine (HCQ) in patients with relapsed or refractory (R/R) clear cell sarcoma (CCS)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS11595-TPS11595

2022

Volltextzugriff (PDF)

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma

Journal of clinical oncology, 2016-11, Vol.34 (32), p.3898-3905

2016

Volltextzugriff (PDF)

OER-073: A Multi-Center Phase II Study Evaluating the Role of Pazopanib in Angiosarcoma

Cancer, 2022-08, Vol.128 (19), p.3516-3522

2022

Volltextzugriff (PDF)

Peak study: A phase 3, randomized, open-label multicenter clinical study of bezuclastinib (CGT9486) and sunitinib in combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST)

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.TPS766-TPS766

2024

Volltextzugriff (PDF)

RINGSIDE phase 2/3 trial of AL102 for treatment of desmoid tumors (DT): Phase 2 results

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11515-11515

2023

Volltextzugriff (PDF)

A phase II trial with safety lead-in to evaluate the addition of sotigalimab, a CD40 agonistic monoclonal antibody, to standard-of-care doxorubicin for the treatment of advanced sarcoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11565-11565

2023

Volltextzugriff (PDF)

Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1

Journal of clinical oncology, 2022-04, Vol.40 (12), p.1291-1300

2022

Volltextzugriff (PDF)

Optimizing brief, focused symptom assessment in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): The FHNSI-10

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18743-e18743

2018

Volltextzugriff (PDF)

A phase II study of cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11505-11505

2023

Volltextzugriff (PDF)

ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11531-11531

2023

Volltextzugriff (PDF)

Evaluating the supportive care costs of severe radiochemotherapy‐induced mucositis and pharyngitis

Cancer, 2008-09, Vol.113 (6), p.1446-1452

2008

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

KollektionPublisher website

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Humans
(16)
Oncology
(14)
Tumors
(13)
Adult
(11)
Female
(9)
Male
(9)
Aged
(8)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Middle Aged
(8)
Head And Neck Neoplasms - Drug Therapy
(6)
Aged, 80 And Over
(5)
Antineoplastic Agents - Therapeutic Use
(5)
Chemotherapy
(5)
Clinical Trials As Topic
(5)
Patients
(5)
Protein Kinase Inhibitors - Therapeutic Use
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies

OER‐073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma

Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

Promising New Molecular Targeted Therapies in Head and Neck Cancer

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

Salivary Gland Malignancies: The Role for Chemotherapy and Molecular Targeted Agents

Evolving strategies for management of desmoid tumor

Impact and Perceptions of Mandatory Tumor Biopsies for Correlative Studies in Clinical Trials of Novel Anticancer Agents

Predictive and Pharmacodynamic Biomarker Studies in Tumor and Skin Tissue Samples of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Erlotinib

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma

Phase 1/2 study of devimistat in combination with hydroxychloroquine (HCQ) in patients with relapsed or refractory (R/R) clear cell sarcoma (CCS)

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma

OER-073: A Multi-Center Phase II Study Evaluating the Role of Pazopanib in Angiosarcoma

Peak study: A phase 3, randomized, open-label multicenter clinical study of bezuclastinib (CGT9486) and sunitinib in combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST)

RINGSIDE phase 2/3 trial of AL102 for treatment of desmoid tumors (DT): Phase 2 results

A phase II trial with safety lead-in to evaluate the addition of sotigalimab, a CD40 agonistic monoclonal antibody, to standard-of-care doxorubicin for the treatment of advanced sarcoma

Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1

Optimizing brief, focused symptom assessment in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): The FHNSI-10

A phase II study of cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas

ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma

Evaluating the supportive care costs of severe radiochemotherapy‐induced mucositis and pharyngitis

Aktive Filter

Suchergebnisse filtern